Printer Friendly

MEDISYS ANNOUNCES 1991 FINANCIAL RESULTS

 MEDISYS ANNOUNCES 1991 FINANCIAL RESULTS
 MINNEAPOLIS, Feb. 13 /PRNewswire/ -- Medisys, Inc. (NASDAQ: MEDS)


announced today that its net revenues increased 72.1 percent to $9,139,573 and its net income increased 97.3 percent to $533,199 for its year ended Dec. 31, 1991, as compared to the prior year. For the fourth quarter net revenues increased 61.9 percent to $2,487,396 and net income increased 52.5 percent to $173,526.
 The increase in net revenues was primarily the result of the company's expanded sales and marketing efforts during 1991 and a full year of operations in Wisconsin and Missouri. The increase in income from operations resulted from the expansion of the company's revenue base and reduction in direct costs as a percentage of net revenues.
 Net income increased by a lower percentage than income from operations due to a higher effective income tax rate in 1991 (32 percent) than in 1990 (8 percent). The higher effective income tax rate was the result of the decrease in net operating loss carryforwards available in 1991 versus 1990. As a result of the higher weighted average common shares outstanding in 1991, net income per common share increased by a lower percentage than net income.
 Medisys, Inc. provides comprehensive home infusion therapy services and products from four regional centers in separate metropolitan area markets. Home infusion therapy involves the intravenous or other administration of physician-prescribed nutrients, antibiotics, chemotherapeutic agents and other medications to patients in their homes.
 MEDISYS, INC.
 Year Ended Percent
 12/31/91 12/31/90 Increase
 Net revenues $9,139,573 $5,309,695 72.1
 Income from operations 1,082,245 498,956 116.9
 Net income $533,199 $270,307 97.3
 Net income per common share $.14 $.09 55.6
 Weighted average common
 shares outstanding 3,802,000 2,905,000 30.9
 Three Months Ended Percent
 12/31/91 12/31/90 Increase
 Net revenues $2,487,396 $1,536,239 61.9
 Income from operations 312,651 164,057 90.6
 Net income $173,526 $113,754 52.5
 Net income per common share $.04 $.04 0.0
 Weighted average common
 shares outstanding 4,242,000 3,173,000 33.7
 -0- 2/13/92
 /CONTACT: William Brummond or David Byrd, 612-835-8300, both of Medisys/
 (MEDS) CO: Medisys, Inc. ST: Minnesota IN: HEA SU: ERN


AL -- MN009 -- 9979 02/13/92 17:19 EST
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Feb 13, 1992
Words:403
Previous Article:UNITED AIRLINES BEGINS SERVICE TO MONTEVIDEO, SANTIAGO
Next Article:COMMERCIAL AIRCRAFT BUSINESS IMPROVED DRAMATICALLY IN 1991, SAYS McDONNELL DOUGLAS CHAIRMAN
Topics:


Related Articles
WHITEWATER PRODUCTS LTD. ACQUIRES ALL MEDISYS TECHNOLOGIES SHARES
MEDISYS ANNOUNCES FIRST QUARTER RESULTS
MEDISYS TECHNOLOGIES AND BAYLOR COLLEGE OF MEDICINE ANNOUNCE FORMAL SIGNING OF CLINICAL TRIALS AGREEMENT
MEDISYS TECHNOLOGIES, INC. SIGNS LETTER OF INTENT WITH BUSSMANN, COOPER INDUSTRIES, INC.
MEDISYS TECHNOLOGIES, INC. ANNOUNCES AFFILIATION WITH LSU AND NASA
/C O R R E C T I O N -- MEDISYS TECHNOLOGIES, INC./
JANE COOPER JOINS MEDISYS TECHNOLOGIES, INC. BOARD OF DIRECTORS
/C O R R E C T I O N -- MEDISYS TECHNOLOGIES, INC./(Correction Notice)
Medisys(R) Technologies Announces Appointment of Douglas R. Eger to the Board of Directors
Medisys(R) Technologies, Inc. Signs 'Letter of Intent' to Acquire Manufacturing Company.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters